Owner Alcon, Inc.

Inventors Castillo, Ernesto J.; Yanni, John M.; Gamache, Daniel A.; Miller, Steven T.

Agent Blake Dawson Patent Attorneys

Pub. Number AU-B-2003299696

PCT Number PCT/US2003/0403

PCT Pub. Number WO2004/058273

Priority 60/436,255 24.12.02 US

Filing date 18 December 2003

Wipo publication date 22 July 2004

Acceptance publication date 13 August 2009

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/573 (2006.01)

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds